Belinostat and Isotretinoin in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery

NCT00334789 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

51

Enrollment

NIH

Sponsor class

Conditions

Adult Solid Neoplasm

Interventions

DRUG: Belinostat
DRUG: Isotretinoin
OTHER: Pharmacological Study

Sponsor

National Cancer Institute (NCI)